VERANDERTE PHOSPHODIESTERASE-AKTIVITAT DER LEUKOZYTEN BEI ATOPISCHEM EKZEM

Translated title of the contribution: Abnormal leukocyte phosphodiesterase activity in atopic dermatitis

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Leukocytes of patients with atopic eczema exhibit a variety of biochemical abnormalities, particularly an alteration in cyclic nucleotide metabolism. The basic defect is an elevation of phosphodiesterase activity in these cells, which leads to a diminished modulation of cellular immune function by cAMP. This, in turn, leads to an elevation of IgE synthesis and enhanced release of inflammatory mediators from mast cells and basophils. The phosphodiesterase defect offers new approaches to the treatment of atopic eczema.

Translated title of the contributionAbnormal leukocyte phosphodiesterase activity in atopic dermatitis
Original languageGerman
Pages (from-to)258-261
Number of pages4
JournalHautarzt
Volume38
Issue number5
StatePublished - Jan 1 1987

ASJC Scopus subject areas

  • Dermatology

Fingerprint Dive into the research topics of 'Abnormal leukocyte phosphodiesterase activity in atopic dermatitis'. Together they form a unique fingerprint.

Cite this